Enric Rello

Chief Financial Officer (CFO)

Therapeutic Areas

Drug	Indication	Phase
Iadademstat (ORY-1001)	Acute Myeloid Leukemia (AML)	Phase 2
Vafidemstat (ORY-2001)	Multiple Sclerosis, Alzheimer's aggression	Phase 2b